REJ-16898-38672 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-02-05
Dose 1 — Pfizer-BioNTech
2021-02-11
Registered in v-safe
2021-02-11
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-02-12
Health check-in — day 7, dose 1
Feeling: Good · Fatigue or tiredness, Nausea

Adult check-in
2021-02-19
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-02-26
Dose 2 — Pfizer-BioNTech
2021-02-27
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Adult check-in
2021-02-28
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Headache, Fatigue or tiredness

Adult check-in
2021-03-01
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-03-02
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Fatigue or tiredness, Nausea

Adult check-in
2021-03-03
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-03-08
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-03-12
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-03-19
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-03-26
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-04-02
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-04-11
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-05-30
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-08-27
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-12-06
Dose 3 — Pfizer-BioNTech
2022-02-27
Health check-in — 12 months, dose 2
Feeling: Good

Adult check-in
2022-09-15
Dose 4 — Pfizer-BioNTech
2022-09-17
Health check-in — days 1–6 daily, dose 4
Feeling: Good · None

Adult check-in
2022-09-18
Health check-in — days 1–6 daily, dose 4
Feeling: Good · None

Adult check-in
2022-09-19
Health check-in — days 1–6 daily, dose 4
Feeling: Good · None

Adult check-in
2022-09-21
Health check-in — days 1–6 daily, dose 4
Feeling: Good · None

Adult check-in
2022-09-22
Health check-in — day 7, dose 4
Feeling: Good · None

Adult check-in
2022-09-29
Health check-in — day 14, dose 4
Feeling: Good

Adult check-in
2022-10-06
Health check-in — day 21, dose 4
Feeling: Good

Adult check-in
2022-10-20
Health check-in — day 35, dose 4
Feeling: Good

Adult check-in
2022-10-27
Health check-in — day 42, dose 4
Feeling: Good

Adult check-in
2023-03-20
Survey response — 6 months, dose 4
MedDRA: Nasal congestion, SARS-CoV-2 test negative, Upper-airway cough syndrome — Feeling: Poor · Be unable to do your normal daily activities

MedDRA releases: 2024-11

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-02-05	Pfizer-BioNTech
2	2021-02-26	Pfizer-BioNTech
3	2021-12-06	Pfizer-BioNTech	No
4	2022-09-15	Pfizer-BioNTech	No

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Nasal congestion	·	·	✓
SD	SARS-CoV-2 test negative	·	·	✓
SD	Upper-airway cough syndrome	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release